Internal restructuring
Nord Ovest; Lombardia; Milano
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

176 jobs
Number of planned job losses
Job loss
Announcement Date
20 October 2015
Employment effect (start)
1 January 2016
Foreseen end date


Boehringer Ingelheim Italia, the Italian subsidiary of the pharmaceutical Boehringer Ingelheim group, announced 176 dismissals at its site in Milan.

The management explained the turnover of its ‘Prescription Medicine’ Division has been shrinking also due to restrictions on public incentives to the purchase of pharmaceutical products and to the expiry of the patent protection of some products.

The exits will affect about 30% of the workforce employed at the site. The mother company already disclosed the intention to implement further cuts over the 2016-2020 period.

Unions deemed the decision dramatic as the group already closed an Italian plant in 2012. Unions lamented the management is not available to discuss a strategic plan for the Italian site and, as a result, they announced strikes.


  • 20 October 2015: Il Fatto Quotidiano
  • 20 October 2015: Rassegna Sindacale
  • 28 October 2015: MI-Tomorrow


Eurofound (2015), Boehringer Ingelheim Italia, Internal restructuring in Italy, factsheet number 91304, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/91304.